|
FRAS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.24789067967868E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.80355730350357E-12 |
| Normal-vs-Stage2 |
3.33066907387547E-14 |
| Normal-vs-Stage3 |
3.82915921193216E-13 |
| Normal-vs-Stage4 |
1.62825308791525E-12 |
| Stage1-vs-Stage2 |
2.737800E-01 |
| Stage1-vs-Stage3 |
7.666400E-01 |
| Stage1-vs-Stage4 |
1.931890E-02 |
| Stage2-vs-Stage3 |
2.478400E-01 |
| Stage2-vs-Stage4 |
3.384200E-01 |
| Stage3-vs-Stage4 |
2.977600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.54871728961371E-14 |
| Normal-vs-AfricanAmerican |
3.7175999999528E-06 |
| Normal-vs-Asian |
1.55699897419481E-11 |
| Caucasian-vs-AfricanAmerican |
3.739000E-01 |
| Caucasian-vs-Asian |
2.856000E-01 |
| AfricanAmerican-vs-Asian |
7.168800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14273043752655E-14 |
| Normal-vs-Female |
2.34923192010683E-13 |
| Male-vs-Female |
6.659900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.81055170855871E-12 |
| Normal-vs-Age(41-60Yrs) |
1.70341518668238E-12 |
| Normal-vs-Age(61-80Yrs) |
1.73894232347038E-12 |
| Normal-vs-Age(81-100Yrs) |
3.25270000001154E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.939200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.070200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.132200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.807200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.360600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.415600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.356850E-01 |
| Classical-VS-Follicular |
7.508200E-01 |
| Classical-VS-Other |
4.920000E-01 |
| Classical-VS-Normal |
3.7070346792234E-13 |
| Tall-VS-Follicular |
4.748800E-01 |
| Tall-VS-Other |
3.469200E-01 |
| Tall-VS-Normal |
4.81836792687318E-14 |
| Follicular-VS-Other |
3.487400E-01 |
| Follicular-VS-Normal |
5.23914245320611E-13 |
| Other-VS-Normal |
6.278400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.84086079713097E-12 |
| Normal-vs-N1 |
5.48450174164827E-14 |
| N0-vs-N1 |
3.647000E-01 |
|
|
